Brief: Lexaria's Glp-1 Human Pilot Study #3 Begins Dosing
Oct 9 (Reuters) - Lexaria Bioscience Corp LEXX.O :
* LEXARIA BIOSCIENCE CORP: LEXARIA'S GLP-1 HUMAN PILOT STUDY
#3
BEGINS DOSING
Source text for Eikon: ID:
Further company coverage: LEXX.O
((Reuters.Briefs@thomsonreuters.com;))